Crossmark

Efficacy of different doses of platelet-rich plasma for moderate carpal tunnel syndrome: study protocol for a prospective, randomized, controlled trial in Guangzhou, China

Crossref DOI link: https://doi.org/10.1186/s13063-026-09538-1

Published Online: 2026-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Yuxi

Lu, Ying

Wei, Zhenhai

Li, Zhipeng

Guo, Mengxia

Xu, Guobin

Yin, Lianjun

Kuang, Li

Guo, Jisheng

Feng, Huiting

Hu, Wenjie

Jiang, Li https://orcid.org/0000-0002-5759-9689
Funding

Funding for this research was provided by:

Guangzhou Municipal Science and Technology Project (202206010195)
License Information

Text and Data Mining valid from 2026-02-25

Version of Record valid from 2026-04-07
More Information

Article History

Received: 26 April 2025

Accepted: 2 February 2026

First Online: 25 February 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below